By Ben Glickman BeiGene's trial of the use of tislelizumab to treat resectable non-small cell lung cancer, when combined with chemotherapy, reached its dual.
Over the past decade, a series of drugs and vaccines that use our immune systems to fight cancer have arrived. Survival times for some deadly cancers are.
By Anthony O. Goriainoff AstraZeneca and Daiichi Sankyo said that datopotamab deruxtecan, a cancer drug, combined with the Imfinzi cancer treatment with or.